Elixir Capital

Why is Elixir Capital Ltd falling/rising?

As of 10-Aug, Elixir Capital Ltd's stock price is rising to 105.60, reflecting a 2.13% increase after a trend reversal. Despite recent declines, investor interest has surged, contributing to a year-to-date gain of 6.67%.

As of 10-Aug, Elixir Capital Ltd's stock price is rising, currently at 105.60, reflecting an increase of 2.2 (2.13%). This upward movement follows a trend reversal after three consecutive days of decline. The stock has outperformed its sector by 3.96% today, indicating a positive shift in investor sentiment. Additionally, the stock reached an intraday high of Rs 108.8, marking a 5.22% increase during the trading day. <BR><BR>Investor participation has also seen a significant rise, with delivery volume on 06 August increasing by 304.84% compared to the 5-day average, suggesting heightened interest in the stock. Despite the recent downturn over the past week and month, where the stock fell by 9.94% and 11.26% respectively, the year-to-date performance remains positive at +6.67%. This combination of factors contributes to the current rise in Elixir Capital Ltd's stock price.

Which are the latest news on Elixir Capital?

When is the next results date for Elixir Capital Ltd?

The next results date for Elixir Capital Ltd is 13 August 2026.

The next results date for Elixir Capital Ltd is scheduled for 13 August 2026.

How big is Elixir Capital?

As of 10th June, Elixir Capital Ltd has a market capitalization of 64.00 Cr, with Net Sales of 34.22 Cr and a Net Profit of 3.03 Cr reported in the latest four quarters. Shareholder's Funds are 56.77 Cr and Total Assets amount to 115.58 Cr as of March 2025.

As of 10th June, Elixir Capital Ltd has a market capitalization of 64.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Elixir Capital reported Net Sales of 34.22 Cr and a Net Profit of 3.03 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 56.77 Cr and Total Assets of 115.58 Cr.

Who are in the management team of Elixir Capital?

The management team of Elixir Capital consists of Dipan Mehta (Chairman & Non-Executive Director), Radhika Mehta (Executive Director), Dilip Kapadia (Independent Non-Executive Director), and Suril V Shah (Independent Non-Executive Director).

The management team of Elixir Capital includes the following individuals:<BR><BR>1. **Dipan Mehta** - Chairman & Non-Executive Director<BR>2. **Radhika Mehta** - Executive Director / Whole Time Director<BR>3. **Dilip Kapadia** - Independent Non-Executive Director<BR>4. **Suril V Shah** - Independent Non-Executive Director<BR><BR>If you need more details about their roles or the company, feel free to ask!

Should I buy, sell or hold Elixir Capital Ltd?

Who are the peers of the Elixir Capital?

Elixir Capital's peers include Apoorva Leasing, Paras Petrofils, Hiliks Technolog, Everlon Fin., HB Portfolio, BAMPSL Sec., Gowra Leasing, SPA CAPT SER, and Mega Corp. Elixir Capital has average management risk and below-average growth, with a 1-year return of -13.54%, better than Paras Petrofils but worse than SPA CAPT SER, which has the highest return at 38.19%.

Peers: The peers of Elixir Capital are Apoorva Leasing, Paras Petrofils, Hiliks Technolog, Everlon Fin., HB Portfolio, BAMPSL Sec., Gowra Leasing, SPA CAPT SER, and Mega Corp.<BR><BR>Quality Snapshot: Excellent management risk is observed at Apoorva Leasing, Hiliks Technolog, HB Portfolio, BAMPSL Sec., Gowra Leasing, SPA CAPT SER, and Mega Corp., while Average management risk is found at Elixir Capital and Everlon Fin. Below Average management risk is noted for Paras Petrofils and the rest. Growth is classified as Good for Hiliks Technolog and Excellent for Gowra Leasing, while Below Average growth is seen at Elixir Capital, Everlon Fin., Apoorva Leasing, HB Portfolio, and the rest. Capital Structure is Excellent for Apoorva Leasing, Hiliks Technolog, HB Portfolio, Elixir Capital, BAMPSL Sec., Gowra Leasing, SPA CAPT SER, and Mega Corp., while Good is noted for Everlon Fin. and the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is SPA CAPT SER at 38.19%, while the lowest is Paras Petrofils at -26.97%. Elixir Capital's 1-year return is -13.54%, which is better than Paras Petrofils but worse than SPA CAPT SER. Additionally, the six-month return is negative for Gowra Leasing, HB Portfolio, BAMPSL Sec., and Everlon Fin.

What does Elixir Capital do?

Elixir Capital Ltd is a BSE-listed NBFC focused on trading, investment in shares, and providing research and advisory services. As of March 2026, it reported negative net sales and profit, with a market cap of INR 64 Cr.

Overview: <BR>Elixir Capital Ltd is a BSE-listed financial services holding company operating in the Non Banking Financial Company (NBFC) sector, focusing on trading and investment in shares, as well as providing research and advisory services.<BR><BR>History: <BR>Elixir Capital Ltd was incorporated in 1994 and was formerly known as Axis Capital Markets (India) Ltd. The latest quarterly results reported are for March 2026, showing negative sales and profit figures.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: -1 Cr (Quarterly Results - Mar 2026) <BR>Most recent Net Profit: -5 Cr (Quarterly Results - Mar 2026) <BR>Market-cap value: INR 64 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 20.00 <BR>Industry P/E: 20 <BR>Dividend Yield: 1.11% <BR>Debt Equity: 0.69 <BR>Return on Equity: 5.13% <BR>Price to Book: 1.06 <BR><BR>Contact Details: <BR>Address: 58 Mittal Chambers, 228 Nariman Point Mumbai Maharashtra : 400021 <BR>Tel: 91-22-61151919 <BR>Email: dipanmehta@vsnl.com <BR>Website: http://www.elixircapital.in

Are Elixir Capital Ltd latest results good or bad?

Elixir Capital Ltd's latest Q4 FY26 results are concerning, showing a net profit of -₹5.43 crore and negative net sales of -₹1.10 crore, indicating significant operational distress. The company's performance is classified as a "Strong Sell," raising serious questions about its future viability.

Elixir Capital Ltd's latest results for Q4 FY26 are concerning and indicate significant operational distress. The company reported a consolidated net profit of -₹5.43 crore, which represents a staggering decline of 235.07% compared to the previous quarter. This is a sharp contrast to the profit of ₹4.02 crore reported in Q3 FY26. <BR><BR>Additionally, net sales also turned negative at -₹1.10 crore, reflecting a decline of 108.26% quarter-on-quarter and a dramatic year-on-year decrease of 389.47%. This negative sales figure suggests that the company may have experienced substantial trading losses or reversals of previously recognized income.<BR><BR>The operating profit margin, while technically reported at 844.35%, is misleading due to the negative sales base, underscoring the severity of the situation. The return on equity has also collapsed to -1.05%, a stark fall from the historical average of 24.22%, indicating that shareholder capital is currently being destroyed rather than generating returns.<BR><BR>Overall, these results highlight critical challenges for Elixir Capital, raising serious questions about the sustainability of its business model and operational viability moving forward. The company's performance is classified as a "Strong Sell," reflecting deep-seated concerns about its future prospects.

Is Elixir Capital overvalued or undervalued?

As of November 17, 2025, Elixir Capital is considered overvalued with a PE ratio of -90.87 and an EV to EBITDA of 60.62, significantly underperforming its peers and the market, evidenced by a year-to-date return of -70.74%.

As of 17 November 2025, Elixir Capital's valuation grade has moved from attractive to very expensive, indicating a significant shift in its market perception. The company is currently overvalued, as evidenced by its PE ratio of -90.87, an EV to EBITDA ratio of 60.62, and a Price to Book Value of 0.95. These ratios suggest that the company's earnings and operational performance are not aligned with its market price, raising concerns about its valuation.<BR><BR>When compared to peers, Elixir Capital's metrics stand out unfavorably. For instance, Bajaj Finance has a PE ratio of 34.85 and an EV to EBITDA of 19.61, while Life Insurance boasts a PE ratio of 11.33 and an EV to EBITDA of 9.36, both of which highlight the relative overvaluation of Elixir Capital. Additionally, the company's recent stock performance has been poor, with a year-to-date return of -70.74%, significantly underperforming the Sensex's 8.72% return, further reinforcing the notion that Elixir Capital is currently overvalued.

How has been the historical performance of Elixir Capital?

Elixir Capital has experienced significant growth in net sales and total operating income, rising from 3.76 Cr in Mar'23 to 35.37 Cr in Mar'25, despite declines in profitability metrics and increased expenditures. The company shows a recovery phase with improved cash flow and asset growth, although profit after tax decreased from 20.96 Cr in Mar'24 to 12.64 Cr in Mar'25.

Answer:<BR>The historical performance of Elixir Capital shows significant fluctuations in key financial metrics over the years.<BR><BR>Breakdown:<BR>Elixir Capital's net sales have shown a notable increase from 3.76 Cr in Mar'23 to 35.37 Cr in Mar'25, indicating a strong recovery and growth trajectory. Total operating income followed a similar trend, rising from 3.76 Cr in Mar'23 to 35.37 Cr in Mar'25. However, total expenditure also increased, from 5.70 Cr in Mar'23 to 15.33 Cr in Mar'25, reflecting higher employee costs and other expenses. Operating profit (PBDIT) saw a peak of 27.43 Cr in Mar'24 but dropped to 20.87 Cr in Mar'25, while profit before tax decreased from 26.08 Cr in Mar'24 to 18.02 Cr in Mar'25. The profit after tax also declined from 20.96 Cr in Mar'24 to 12.64 Cr in Mar'25, resulting in a decrease in the PAT margin from 65.44% to 36.31%. On the balance sheet, total assets increased from 96.38 Cr in Mar'24 to 115.58 Cr in Mar'25, with total liabilities also rising from 96.38 Cr to 115.58 Cr, indicating a balanced growth in both assets and liabilities. Cash flow from operating activities turned positive at 2.00 Cr in Mar'25 after a negative trend in the previous year, while closing cash and cash equivalents increased to 10.00 Cr in Mar'25 from 9.00 Cr in Mar'24. Overall, Elixir Capital's financial performance reflects a recovery phase with growth in sales and assets, despite some declines in profitability metrics in the most recent year.

Who are the top shareholders of the Elixir Capital?

The top shareholder of Elixir Capital is Dipan Anil Mehta, holding 36.6%. Other significant shareholders include Shamyak Investment Private Limited with 6.47% and individual investors collectively owning 17.72%.

The top shareholders of Elixir Capital include the promoters, with Dipan Anil Mehta holding the largest share at 36.6%. There are no pledged promoter holdings, and mutual funds and foreign institutional investors do not hold any shares in the company. The highest public shareholder is Shamyak Investment Private Limited, which owns 6.47%. Additionally, individual investors collectively hold 17.72% of the shares.

What is the technical trend for Elixir Capital?

As of May 16, 2025, Elixir Capital's technical trend has shifted to a moderate bearish stance, supported by bearish MACD and moving averages, while Bollinger Bands indicate mild bearishness, despite mixed signals from the KST.

As of 16 May 2025, the technical trend for Elixir Capital has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength. The weekly MACD indicates a bearish trend, while the daily moving averages also confirm a bearish outlook. The Bollinger Bands on both weekly and monthly time frames are mildly bearish, further supporting the negative sentiment. The KST shows a mildly bullish signal on the weekly but is mildly bearish on the monthly, indicating mixed signals in the longer term. Overall, the indicators suggest a prevailing bearish trend for Elixir Capital.

Has Elixir Capital declared dividend?

Elixir Capital Ltd has declared a 12% dividend, amounting to 1.2 per share, with an ex-date of August 16, 2024. While the dividend yield is 1%, recent total returns show significant fluctuations, particularly a -58.84% return over the last 6 months, but positive returns over longer periods.

Elixir Capital Ltd has declared a 12% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 12%<BR>- Amount per share: 1.2<BR>- Ex-date: 16 Aug 2024<BR><BR>Dividend Yield: 1%<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -58.84%, the dividend return was 0%, resulting in a total return of -58.84%.<BR><BR>Over the past year, the price return was 6.11%, the dividend return was 0.96%, leading to a total return of 7.07%.<BR><BR>In the 2-year period, the price return was 182.2%, with a dividend return of 5.35%, culminating in a total return of 187.55%.<BR><BR>For the 3-year period, the price return was 155.54%, the dividend return was 7.13%, resulting in a total return of 162.67%.<BR><BR>In the 4-year period, the price return was 252.5%, the dividend return was 10.20%, leading to a total return of 262.7%.<BR><BR>Over the last 5 years, the price return was 327.27%, with a dividend return of 19.67%, resulting in a total return of 346.94%.<BR><BR>Overall, while Elixir Capital Ltd has declared a dividend, the recent total returns indicate significant fluctuations, particularly in the short term, with notable positive returns over longer periods. The dividend yield is relatively low, suggesting that while there is a return from dividends, the focus may be more on price appreciation in the stock.